Levin Capital Strategies’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7
Closed -$4K 280
2022
Q3
$4K Hold
7
﹤0.01% 237
2022
Q2
$5K Sell
7
-6
-46% -$8.89K ﹤0.01% 269
2022
Q1
$33K Sell
13
-10
-43% -$21.2K ﹤0.01% 306
2021
Q4
$59K Buy
23
+18
+360% +$62.6K 0.01% 316
2021
Q3
$21K Sell
5
-22
-81% -$111K ﹤0.01% 352
2021
Q2
$159K Buy
27
+11
+69% +$71K 0.02% 311
2021
Q1
$127K Sell
16
-25
-61% -$265K 0.01% 289
2020
Q4
$252K Buy
41
+21
+105% +$129K 0.03% 227
2020
Q3
$134K Buy
20
+2
+11% +$14.8K 0.02% 239
2020
Q2
$112K Sell
18
-7
-28% -$29.7K 0.02% 179
2020
Q1
$80K Sell
25
-2
-7% -$8.31K 0.01% 162
2019
Q4
$156K Buy
27
+12
+80% +$113K 0.02% 190
2019
Q3
$184K Buy
15
+4
+36% +$32.1K 0.02% 176
2019
Q2
$90K Sell
11
-4
-27% -$46.9K 0.01% 199
2019
Q1
$197K Sell
15
-5
-25% -$85.1K 0.02% 172
2018
Q4
$301K Buy
20
+5
+33% +$117K 0.01% 198
2018
Q3
$566K Sell
15
-3
-17% -$98.8K 0.01% 176
2018
Q2
$698K Buy
+18
New +$683K 0.01% 167

Other funds holding TTOO

Levin Capital Strategies's TTOO Position: Q4 2022 in Review

Levin Capital Strategies sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 7 shares — an estimated $4K sold.

Levin Capital Strategies first reported a position in TTOO in Q2 2018 and held it in 18 quarters. The position peaked at $698K in Q2 2018. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Levin Capital Strategies reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Levin Capital Strategies sold 7 T2 Biosystems, Inc shares in Q4 2022, an estimated $4K.
  • Levin Capital Strategies first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 18 quarters.
  • Levin Capital Strategies's T2 Biosystems, Inc position peaked at $698K in Q2 2018.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Levin Capital Strategies's 13F filing for Q4 2022, filed 13 Feb 2023.